Items where authors include "Marples, M."

Article

Woll, P.J. orcid.org/0000-0002-1118-0831, Gaunt, P., Gaskell, C. et al. (12 more authors) (2023) Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata. British Journal of Cancer, 129 (9). pp. 1490-1499. ISSN 0007-0920

Merry, E., Marples, M., Danson, S. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2020) Effect of carboplatin when administered after dacarbazine failure : clinical benefit of sequential therapy. Molecular and Clinical Oncology, 13 (6). 73. pp. 1-4. ISSN 2049-9450

Corrie, P.G., Marshall, A., Nathan, P.D. et al. (36 more authors) (2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8). pp. 1843-1852.

Seddon, B., Strauss, S.J., Whelan, J. et al. (16 more authors) (2017) Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. The Lancet Oncology, 18 (10). pp. 1397-1410. ISSN 1470-2045

Zekri, J., Marples, M., Taylor, D. et al. (3 more authors) (2017) Complications of bone metastases from malignant melanoma. Journal of Bone Oncology, 8. pp. 13-17. ISSN 2212-1374

Ahmad, S.S., Qian, W., Ellis, S. et al. (26 more authors) (2015) Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients. Melanoma Research, 25 (5). pp. 432-442. ISSN 0960-8931

Corrie, P., Marshall, A., Dunn, J. et al. (17 more authors) (2014) Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. Lancet Oncology, 15 (6). pp. 620-630. ISSN 1470-2045

Ward, S.E. orcid.org/0000-0002-3344-0913, Kaltenthaler, E. orcid.org/0000-0002-6185-8321, Cowan, J. et al. (3 more authors) (2006) The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. British Journal of Cancer, 95 (1). pp. 27-34. ISSN 0007-0920